Azenta, Inc. (AZTA) 10-Year Financial Performance & Capital Metrics

AZTA • • Industrial / General

HealthcareMedical InstrumentsBiopharma & Life Science ToolsLaboratory Supplies & Services

AboutAzenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.Show more

Revenue $594M -9.5%
EBITDA $81M +173.6%
Net Income -$60M +63.8%
EPS (Diluted) -1.30 +57.9%
Gross Margin 45.52% +13.4%
EBITDA Margin 13.63% +181.4%
Operating Margin 4.12% +113.5%
Net Margin -10.02% +59.9%
ROE -3.4% +55.4%
ROIC 1.21% +113.9%
Debt/Equity 0.03 -25.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Share count reduced 13.7% through buybacks
✓Trading at only 1.1x book value

✗Weaknesses

✗Sales declining 7.9% over 5 years
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y0.72%

5Y-7.92%

3Y2.25%

TTM-9.49%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM63.78%

EPS CAGR

10Y-

5Y-

3Y-

TTM56.23%

ROCE

10Y Avg1.26%

5Y Avg-2.66%

3Y Avg-3.28%

Latest1.32%

Peer Comparison

Laboratory Supplies & Services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AVTRAvantor, Inc.	8.2B	12.02	11.56	-2.64%	10.31%	10.94%	8.44%	0.71
POAIPredictive Oncology Inc.	24.03M	7.08	-3.16	-0.24%	-115.81%	-302.42%
AZTAAzenta, Inc.	1.84B	39.91	-30.70	-9.52%	-10.01%	-3.45%	2.09%	0.03

Profit & Loss

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Sales/Revenue+	560.32M	692.88M	631.56M	781.87M	897.27M	513.7M	555.5M	665.07M	656.32M	593.82M
Revenue Growth %	0.01%	0.24%	-0.09%	0.24%	0.15%	-0.43%	0.08%	0.2%	-0.01%	-0.1%
Cost of Goods Sold+	362.24M	425.48M	385.48M	465.11M	517.25M	269.89M	299.91M	401.93M	392.96M	323.54M
COGS % of Revenue	0.65%	0.61%	0.61%	0.59%	0.58%	0.53%	0.54%	0.6%	0.6%	0.54%
Gross Profit+	198.08M	267.4M	246.08M	316.76M	380.02M	243.81M	255.58M	263.14M	263.37M	270.28M
Gross Margin %	0.35%	0.39%	0.39%	0.41%	0.42%	0.47%	0.46%	0.4%	0.4%	0.46%
Gross Profit Growth %	0.05%	0.35%	-0.08%	0.29%	0.2%	-0.36%	0.05%	0.03%	0%	0.03%
Operating Expenses+	181.8M	200.06M	213.96M	268.33M	300.2M	274.51M	279.61M	336.27M	464.05M	297.12M
OpEx % of Revenue	0.32%	0.29%	0.34%	0.34%	0.33%	0.53%	0.5%	0.51%	0.71%	0.5%
Selling, General & Admin	130.26M	153.06M	167.02M	211.96M	241.14M	252.1M	252.06M	316.28M	302.74M	261.56M
SG&A % of Revenue	0.23%	0.22%	0.26%	0.27%	0.27%	0.49%	0.45%	0.48%	0.46%	0.44%
Research & Development	51.54M	47M	46.94M	56.37M	59.06M	22.41M	27.54M	33.96M	33.52M	30.39M
R&D % of Revenue	0.09%	0.07%	0.07%	0.07%	0.07%	0.04%	0.05%	0.05%	0.05%	0.05%
Other Operating Expenses	-579K	-645K	0	-1.46M	-1.39M	0	-266K	-13.97M	127.78M	5.17M
Operating Income+	4.24M	64.11M	31.41M	46.53M	78.46M	-46.55M	-4M	-73.13M	-200.68M	24.46M
Operating Margin %	0.01%	0.09%	0.05%	0.06%	0.09%	-0.09%	-0.01%	-0.11%	-0.31%	0.04%
Operating Income Growth %	-0.75%	14.13%	-0.51%	0.48%	0.69%	-1.59%	0.91%	-17.27%	-1.74%	1.12%
EBITDA+	32.28M	91.31M	68.11M	100.98M	143.95M	10.32M	49.7M	12.46M	-109.93M	80.93M
EBITDA Margin %	0.06%	0.13%	0.11%	0.13%	0.16%	0.02%	0.09%	0.02%	-0.17%	0.14%
EBITDA Growth %	-0.23%	1.83%	-0.25%	0.48%	0.43%	-0.93%	3.81%	-0.75%	-9.82%	1.74%
D&A (Non-Cash Add-back)	28.05M	27.2M	36.7M	54.45M	65.5M	56.87M	53.7M	85.58M	90.74M	56.47M
EBIT	4.11M	14.93M	29.99M	-61.71M	-37.35M	-46.93M	-5.35M	-30.43M	-72.89M	-7.14M
Net Interest Income+	295K	56K	-7.64M	-20.8M	-2.1M	-1.41M	15.7M	43.73M	33.18M	18.78M
Interest Income	452K	464K	1.88M	1.45M	849K	632K	20.29M	43.73M	33.18M	18.78M
Interest Expense	157K	408K	9.52M	22.25M	2.94M	2.04M	4.59M	0	0	0
Other Income/Expense	-284K	46.69M	-10.94M	48.7M	-5.17M	-17.88M	14.8M	42.69M	33.35M	-31.6M
Pretax Income+	3.95M	65.37M	20.47M	9.94M	74.97M	-48.97M	-9.94M	-30.43M	-167.32M	-7.14M
Pretax Margin %	0.01%	0.09%	0.03%	0.01%	0.08%	-0.1%	-0.02%	-0.05%	-0.25%	-0.01%
Income Tax+	75.81M	12.14M	-47.25M	50K	9.94M	-20.1M	1.35M	-17.55M	-3.15M	-30.8M
Effective Tax Rate %	-17.57%	0.96%	5.7%	0.99%	0.87%	0.59%	1.14%	0.47%	0.98%	8.33%
Net Income+	-69.48M	62.61M	116.58M	9.89M	64.85M	-28.87M	-11.29M	-14.26M	-164.17M	-59.5M
Net Margin %	-0.12%	0.09%	0.18%	0.01%	0.07%	-0.06%	-0.02%	-0.02%	-0.25%	-0.1%
Net Income Growth %	-5.89%	1.9%	0.86%	-0.92%	5.56%	-1.45%	0.61%	-0.26%	-10.52%	0.64%
Net Income (Continuing)	-71.86M	10.69M	67.72M	-61.13M	-26.36M	-28.87M	-11.29M	-12.88M	-164.17M	23.66M
Discontinued Operations	0	51.92M	48.75M	0	91.22M	139.62M	0	0	0	-83.16M
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-1.01	0.89	1.64	0.14	0.88	-0.39	-0.15	-0.22	-3.09	-1.30
EPS Growth %	-5.81%	1.88%	0.84%	-0.91%	5.29%	-1.44%	0.62%	-0.47%	-13.05%	0.58%
EPS (Basic)	-1.02	0.90	1.65	0.14	0.88	-0.39	-0.15	-0.22	-3.09	-1.30
Diluted Shares Outstanding	68.51M	70.48M	70.94M	72.39M	73.85M	74.45M	74.9M	66.25M	53.17M	45.9M
Basic Shares Outstanding	68.37M	69.58M	70.49M	71.99M	73.56M	74.23M	74.9M	66.25M	53.17M	45.74M
Dividend Payout Ratio	-	0.45%	0.24%	2.92%	0.46%	-	-	-	-	-

Balance Sheet

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Current Assets+	299.33M	352.01M	564.81M	648.2M	649.45M	777.37M	2.46B	1.42B	832.81M	708.34M
Cash & Short-Term Investments	85.13M	101.65M	243.99M	335.77M	295.72M	227.51M	1.57B	1.02B	462.09M	340.92M
Cash Only	85.09M	101.62M	197.71M	301.64M	295.65M	227.43M	658.27M	678.91M	310.93M	279.78M
Short-Term Investments	39K	28K	46.28M	34.12M	67K	81K	911.76M	338.87M	151.16M	61.14M
Accounts Receivable	106.37M	93.47M	125.19M	165.6M	94.79M	119.88M	163.76M	156.53M	172.71M	142.18M
Days Sales Outstanding	69.29	49.24	72.35	77.31	38.56	85.18	107.6	85.91	96.05	87.39
Inventory	92.57M	106.39M	96.99M	99.44M	114.83M	60.4M	85.54M	128.2M	115.26M	74.96M
Days Inventory Outstanding	93.28	91.27	91.83	78.04	81.03	81.68	104.11	116.42	107.06	84.56
Other Current Assets	15.27M	60.67M	97.89M	0	222.86M	318.53M	507.38M	116.44M	82.75M	150.28M
Total Non-Current Assets+	386.57M	414.62M	531.2M	868.86M	909.67M	1.04B	1.26B	1.47B	1.27B	1.35B
Property, Plant & Equipment	54.88M	58.46M	59.99M	100.67M	117.67M	130.72M	154.47M	205.74M	266.65M	208M
Fixed Asset Turnover	10.21x	11.85x	10.53x	7.77x	7.63x	3.93x	3.60x	3.23x	2.46x	2.85x
Goodwill	202.14M	233.64M	255.88M	488.6M	501.54M	469.36M	513.62M	784.34M	691.41M	702.39M
Intangible Assets	81.84M	83.52M	99.96M	251.17M	218.32M	186.53M	178.4M	294.3M	248.03M	101.81M
Long-Term Investments	33.37M	31.23M	7.24M	2.85M	3.1M	3.6M	352.02M	111.34M	49.45M	247.19M
Other Non-Current Assets	12.35M	6.07M	64.35M	20.51M	64.07M	241.9M	57.09M	70.47M	10.86M	91.12M
Total Assets+	685.9M	766.63M	1.1B	1.52B	1.56B	1.82B	3.72B	2.89B	2.1B	2.06B
Asset Turnover	0.82x	0.90x	0.58x	0.52x	0.58x	0.28x	0.15x	0.23x	0.31x	0.29x
Asset Growth %	-0.1%	0.12%	0.43%	0.38%	0.03%	0.17%	1.04%	-0.22%	-0.27%	-0.02%
Total Current Liabilities+	119.79M	146.78M	165.37M	272.99M	211.12M	345.09M	230.55M	210.93M	204.84M	237.67M
Accounts Payable	41.13M	49.1M	44.72M	58.92M	25.69M	42.36M	38.65M	35.8M	44.43M	37.72M
Days Payables Outstanding	41.44	42.12	42.35	46.24	18.13	57.29	47.04	32.51	41.27	42.56
Short-Term Debt	0	0	2M	829K	827K	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	34.89M	39.82M	44.79M	52.45M	111.5M	162.12M	81.83M	99.23M	104.5M	122.17M
Current Ratio	2.50x	2.40x	3.42x	2.37x	3.08x	2.25x	10.67x	6.73x	4.07x	2.98x
Quick Ratio	1.73x	1.67x	2.83x	2.01x	2.53x	2.08x	10.30x	6.12x	3.50x	2.66x
Cash Conversion Cycle	121.13	98.39	121.84	109.11	101.47	109.57	164.67	169.82	161.83	129.4
Total Non-Current Liabilities+	12.42M	12.21M	212.81M	104.77M	134.39M	149.09M	122.19M	140.29M	126.23M	94.92M
Long-Term Debt	0	0	194.07M	50.31M	49.59M	49.68M	0	0	0	51.24M
Capital Lease Obligations	0	0	0	0	18.91M	45.09M	49.23M	60.44M	60.13M	51.24M
Deferred Tax Liabilities	5.59M	5.43M	8.24M	38.91M	36.97M	15M	66.24M	0	54.18M	18.25M
Other Non-Current Liabilities	9.51M	8.46M	11.6M	33.82M	48.24M	41.3M	72.96M	79.86M	11.93M	23.35M
Total Liabilities	132.22M	158.98M	378.18M	377.76M	345.51M	494.18M	352.74M	351.22M	331.07M	332.6M
Total Debt+	0	0	196.07M	51.14M	82.27M	94.77M	49.23M	60.44M	70.68M	51.24M
Net Debt	-85.09M	-101.62M	-1.64M	-250.5M	-213.38M	-132.66M	-609.05M	-618.47M	-240.25M	-228.54M
Debt / Equity	-	-	0.27x	0.04x	0.07x	0.07x	0.01x	0.02x	0.04x	0.03x
Debt / EBITDA	-	-	2.88x	0.51x	0.57x	9.18x	0.99x	4.85x	-	0.63x
Net Debt / EBITDA	-2.64x	-1.11x	-0.02x	-2.48x	-1.48x	-12.85x	-12.25x	-49.64x	-	-2.82x
Interest Coverage	26.99x	157.14x	3.30x	2.09x	26.65x	-22.85x	-0.87x	-	-	-
Total Equity+	553.69M	607.64M	717.83M	1.14B	1.21B	1.33B	3.36B	2.53B	1.77B	1.73B
Equity Growth %	-0.12%	0.1%	0.18%	0.59%	0.07%	0.09%	1.54%	-0.25%	-0.3%	-0.02%
Book Value per Share	8.08	8.62	10.12	15.74	16.43	17.80	44.91	38.25	33.27	37.63
Total Shareholders' Equity	553.69M	607.64M	717.83M	1.14B	1.21B	1.33B	3.36B	2.53B	1.77B	1.73B
Common Stock	821K	833K	841K	857K	873K	878K	885K	713K	590K	594K
Retained Earnings	-1.12B	-1.08B	-994.07M	-586.08M	-551.07M	-470.05M	1.66B	1.64B	1.48B	1.42B
Treasury Stock	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M
Accumulated OCI	15.17M	15.21M	13.59M	3.51M	21.92M	19.35M	-83.92M	-62.43M	-13.46M	-22.21M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Cash from Operations+	39.55M	96.22M	73.96M	90.9M	37.87M	149.86M	-466.05M	17.49M	50.29M	72.18M
Operating CF Margin %	0.07%	0.14%	0.12%	0.12%	0.04%	0.29%	-0.84%	0.03%	0.08%	0.12%
Operating CF Growth %	-0.1%	1.43%	-0.23%	0.23%	-0.58%	2.96%	-4.11%	1.04%	1.88%	0.44%
Net Income	-69.48M	62.61M	116.46M	437.75M	64.85M	110.75M	2.13B	-14.26M	-164.17M	-59.5M
Depreciation & Amortization	28.05M	28.15M	37.43M	54.45M	65.5M	65.33M	53.7M	85.58M	90.74M	61.21M
Stock-Based Compensation	11.74M	17.28M	19.82M	13.05M	10.65M	34.86M	10.67M	9.38M	14.47M	20.88M
Deferred Taxes	70.27M	517K	-45.22M	-15.16M	-5.41M	-17.27M	24.47M	-28.65M	-16.07M	-27.15M
Other Non-Cash Items	-1.27M	-11.64M	-7.94M	-411.12M	-90.72M	14.8M	-2.62B	-16.71M	122.28M	99.75M
Working Capital Changes	242K	-691K	-46.59M	4.86M	-12.67M	-51.21M	-72.13M	-17.85M	3.04M	-23M
Change in Receivables	-1.8M	-11.18M	-29.21M	-12.5M	-18.75M	-69.64M	-31.4M	33.99M	-11.59M	-24.56M
Change in Inventory	8.56M	-12.79M	-24.36M	-2.93M	-13.14M	-50.44M	-66.63M	8.25M	3.29M	-3.97M
Change in Payables	-5.14M	7.85M	5.46M	5.21M	792K	30.97M	-3.93M	-14.71M	9.2M	1.04M
Cash from Investing+	-10.87M	-54.19M	-148.47M	211.31M	-22.74M	-146.35M	1.47B	431.38M	224.74M	-90.46M
Capital Expenditures	-12.85M	-12.92M	-12.79M	-23.86M	-39.92M	-52.8M	-77.44M	-39.44M	-37.39M	-33.86M
CapEx % of Revenue	0.02%	0.02%	0.02%	0.03%	0.04%	0.1%	0.14%	0.06%	0.06%	0.06%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	985K	100K	200K	677.88M	-1M	2M	1.66B	29.31M	1.48M	5.35M
Cash from Financing+	-25.96M	-25.92M	170.28M	-191.16M	-27.02M	-25.91M	-62.76M	-844.08M	-659.21M	-9.59M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-27.5M	-27.93M	-28.29M	-28.89M	-29.51M	-29.73M	-7.49M	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-708K	-28K	-318K	0	0	0	-10.4M	-4.99M	0	-11.38M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	26.7M	83.31M	61.18M	67.04M	-2.06M	97.05M	-543.48M	-21.95M	12.9M	38.32M
FCF Margin %	0.05%	0.12%	0.1%	0.09%	-0%	0.19%	-0.98%	-0.03%	0.02%	0.06%
FCF Growth %	-0.03%	2.12%	-0.27%	0.1%	-1.03%	48.16%	-6.6%	0.96%	1.59%	1.97%
FCF per Share	0.39	1.18	0.86	0.93	-0.03	1.30	-7.26	-0.33	0.24	0.84
FCF Conversion (FCF/Net Income)	-0.57x	1.54x	0.63x	9.19x	0.58x	-5.19x	41.29x	-1.23x	-0.31x	-1.21x
Interest Paid	114K	200K	6.54M	20.8M	2.16M	1.44M	469K	0	0	0
Taxes Paid	4.93M	8.14M	21.05M	16.99M	102.01M	38.02M	452.46M	43.07M	2.7M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-11.72%	10.78%	17.59%	1.07%	5.51%	-2.27%	-0.48%	-0.48%	-7.63%	-3.4%
Return on Invested Capital (ROIC)	0.62%	9.87%	3.85%	4.35%	6.23%	-3.18%	-0.15%	-2.35%	-8.74%	1.21%
Gross Margin	35.35%	38.59%	38.96%	40.51%	42.35%	47.46%	46.01%	39.57%	40.13%	45.52%
Net Margin	-12.4%	9.04%	18.46%	1.26%	7.23%	-5.62%	-2.03%	-2.14%	-25.01%	-10.02%
Debt / Equity	-	-	0.27x	0.04x	0.07x	0.07x	0.01x	0.02x	0.04x	0.03x
Interest Coverage	26.99x	157.14x	3.30x	2.09x	26.65x	-22.85x	-0.87x	-	-	-
FCF Conversion	-0.57x	1.54x	0.63x	9.19x	0.58x	-5.19x	41.29x	-1.23x	-0.31x	-1.21x
Revenue Growth	1.38%	23.66%	-8.85%	23.8%	14.76%	-42.75%	8.14%	19.73%	-1.32%	-9.52%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Service	-	-	45.73M	276.82M	323.4M	-	374.55M	387.88M	412.92M	420.63M
Service Growth	-	-	-	505.32%	16.83%	-	-	3.56%	6.45%	1.87%
Product	-	-	150.37M	504.03M	573.88M	-	180.95M	277.19M	243.41M	173.19M
Product Growth	-	-	-	235.20%	13.86%	-	-	53.19%	-12.19%	-28.85%
Services	-	-	-	-	-	332.67M	-	-	-	-
Services Growth	-	-	-	-	-	-	-	-	-	-
Products	-	-	-	-	-	181.04M	-	-	-	-
Products Growth	-	-	-	-	-	-	-	-	-	-
Brooks Life Science Systems	61.57M	81.96M	-	-	-	-	-	-	-	-
Brooks Life Science Systems Growth	-	33.12%	-	-	-	-	-	-	-	-
Brooks Semiconductor Solutions Group	76.97M	77.31M	-	-	-	-	-	-	-	-
Brooks Semiconductor Solutions Group Growth	-	0.43%	-	-	-	-	-	-	-	-
Operatings	138.54M	-	-	-	-	-	-	-	-	-
Operatings Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Europe	-	-	-	-	139.77M	108.81M	104.82M	109.86M	102.77M	107.37M
Europe Growth	-	-	-	-	-	-22.15%	-3.66%	4.80%	-6.45%	4.47%
CHINA	-	-	-	-	-	-	48.09M	51.79M	58.26M	58.35M
CHINA Growth	-	-	-	-	-	-	-	7.68%	12.50%	0.15%
UNITED KINGDOM	-	-	-	-	-	-	-	26.76M	27.45M	35.39M
UNITED KINGDOM Growth	-	-	-	-	-	-	-	-	2.57%	28.91%
Asia Pacific	247.24M	327.86M	262.71M	-	-	-	-	-	39.67M	23.28M
Asia Pacific Growth	-	32.61%	-19.87%	-	-	-	-	-	-	-41.32%
North America	209.73M	242.33M	233.24M	327.25M	340.4M	323.98M	373.61M	359.42M	366.21M	-
North America Growth	-	15.55%	-3.75%	40.30%	4.02%	-4.82%	15.32%	-3.80%	1.89%	-
Africa	-	-	-	-	-	-	-	65.09M	61.96M	-
Africa Growth	-	-	-	-	-	-	-	-	-4.81%	-
Asia Pacific, Other than China	-	-	-	-	417.1M	80.92M	28.97M	52.16M	-	-
Asia Pacific, Other than China Growth	-	-	-	-	-	-80.60%	-64.20%	80.04%	-	-
U	-	240.6M	232.7M	325.3M	-	-	-	-	-	-
U Growth	-	-	-3.28%	39.79%	-	-	-	-	-	-
Asia Pacific And Other	-	-	-	312.24M	-	-	-	-	-	-
Asia Pacific And Other Growth	-	-	-	-	-	-	-	-	-	-
Europe Excluding United Kingdom	-	80.55M	83.92M	92.6M	-	-	-	-	-	-
Europe Excluding United Kingdom Growth	-	-	4.18%	10.34%	-	-	-	-	-	-
G	-	42.14M	51.69M	48.76M	-	-	-	-	-	-
G Growth	-	-	22.67%	-5.66%	-	-	-	-	-	-
Europe, Excluding United Kingdom	66.74M	-	-	-	-	-	-	-	-	-
Europe, Excluding United Kingdom Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Azenta, Inc. (AZTA) reported $594.1M in revenue for fiscal year 2025. This represents a 14% increase from $519.5M in 2012.

Azenta, Inc. (AZTA) saw revenue decline by 9.5% over the past year.

Azenta, Inc. (AZTA) reported a net loss of $59.5M for fiscal year 2025.

Dividend & Returns

Azenta, Inc. (AZTA) has a return on equity (ROE) of -3.4%. Negative ROE indicates the company is unprofitable.

Azenta, Inc. (AZTA) generated $38.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

Azenta, Inc. (AZTA) 10-Year Financial Performance & Capital Metrics

AZTA • • Industrial / General

HealthcareMedical InstrumentsBiopharma & Life Science ToolsLaboratory Supplies & Services

Revenue $594M -9.5%
EBITDA $81M +173.6%
Net Income -$60M +63.8%
EPS (Diluted) -1.30 +57.9%
Gross Margin 45.52% +13.4%
EBITDA Margin 13.63% +181.4%
Operating Margin 4.12% +113.5%
Net Margin -10.02% +59.9%
ROE -3.4% +55.4%
ROIC 1.21% +113.9%
Debt/Equity 0.03 -25.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Share count reduced 13.7% through buybacks
✓Trading at only 1.1x book value

✗Weaknesses

✗Sales declining 7.9% over 5 years
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y0.72%

5Y-7.92%

3Y2.25%

TTM-9.49%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM63.78%

EPS CAGR

10Y-

5Y-

3Y-

TTM56.23%

ROCE

10Y Avg1.26%

5Y Avg-2.66%

3Y Avg-3.28%

Latest1.32%

Peer Comparison

Laboratory Supplies & Services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AVTRAvantor, Inc.	8.2B	12.02	11.56	-2.64%	10.31%	10.94%	8.44%	0.71
POAIPredictive Oncology Inc.	24.03M	7.08	-3.16	-0.24%	-115.81%	-302.42%
AZTAAzenta, Inc.	1.84B	39.91	-30.70	-9.52%	-10.01%	-3.45%	2.09%	0.03

Profit & Loss

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Sales/Revenue+	560.32M	692.88M	631.56M	781.87M	897.27M	513.7M	555.5M	665.07M	656.32M	593.82M
Revenue Growth %	0.01%	0.24%	-0.09%	0.24%	0.15%	-0.43%	0.08%	0.2%	-0.01%	-0.1%
Cost of Goods Sold+	362.24M	425.48M	385.48M	465.11M	517.25M	269.89M	299.91M	401.93M	392.96M	323.54M
COGS % of Revenue	0.65%	0.61%	0.61%	0.59%	0.58%	0.53%	0.54%	0.6%	0.6%	0.54%
Gross Profit+	198.08M	267.4M	246.08M	316.76M	380.02M	243.81M	255.58M	263.14M	263.37M	270.28M
Gross Margin %	0.35%	0.39%	0.39%	0.41%	0.42%	0.47%	0.46%	0.4%	0.4%	0.46%
Gross Profit Growth %	0.05%	0.35%	-0.08%	0.29%	0.2%	-0.36%	0.05%	0.03%	0%	0.03%
Operating Expenses+	181.8M	200.06M	213.96M	268.33M	300.2M	274.51M	279.61M	336.27M	464.05M	297.12M
OpEx % of Revenue	0.32%	0.29%	0.34%	0.34%	0.33%	0.53%	0.5%	0.51%	0.71%	0.5%
Selling, General & Admin	130.26M	153.06M	167.02M	211.96M	241.14M	252.1M	252.06M	316.28M	302.74M	261.56M
SG&A % of Revenue	0.23%	0.22%	0.26%	0.27%	0.27%	0.49%	0.45%	0.48%	0.46%	0.44%
Research & Development	51.54M	47M	46.94M	56.37M	59.06M	22.41M	27.54M	33.96M	33.52M	30.39M
R&D % of Revenue	0.09%	0.07%	0.07%	0.07%	0.07%	0.04%	0.05%	0.05%	0.05%	0.05%
Other Operating Expenses	-579K	-645K	0	-1.46M	-1.39M	0	-266K	-13.97M	127.78M	5.17M
Operating Income+	4.24M	64.11M	31.41M	46.53M	78.46M	-46.55M	-4M	-73.13M	-200.68M	24.46M
Operating Margin %	0.01%	0.09%	0.05%	0.06%	0.09%	-0.09%	-0.01%	-0.11%	-0.31%	0.04%
Operating Income Growth %	-0.75%	14.13%	-0.51%	0.48%	0.69%	-1.59%	0.91%	-17.27%	-1.74%	1.12%
EBITDA+	32.28M	91.31M	68.11M	100.98M	143.95M	10.32M	49.7M	12.46M	-109.93M	80.93M
EBITDA Margin %	0.06%	0.13%	0.11%	0.13%	0.16%	0.02%	0.09%	0.02%	-0.17%	0.14%
EBITDA Growth %	-0.23%	1.83%	-0.25%	0.48%	0.43%	-0.93%	3.81%	-0.75%	-9.82%	1.74%
D&A (Non-Cash Add-back)	28.05M	27.2M	36.7M	54.45M	65.5M	56.87M	53.7M	85.58M	90.74M	56.47M
EBIT	4.11M	14.93M	29.99M	-61.71M	-37.35M	-46.93M	-5.35M	-30.43M	-72.89M	-7.14M
Net Interest Income+	295K	56K	-7.64M	-20.8M	-2.1M	-1.41M	15.7M	43.73M	33.18M	18.78M
Interest Income	452K	464K	1.88M	1.45M	849K	632K	20.29M	43.73M	33.18M	18.78M
Interest Expense	157K	408K	9.52M	22.25M	2.94M	2.04M	4.59M	0	0	0
Other Income/Expense	-284K	46.69M	-10.94M	48.7M	-5.17M	-17.88M	14.8M	42.69M	33.35M	-31.6M
Pretax Income+	3.95M	65.37M	20.47M	9.94M	74.97M	-48.97M	-9.94M	-30.43M	-167.32M	-7.14M
Pretax Margin %	0.01%	0.09%	0.03%	0.01%	0.08%	-0.1%	-0.02%	-0.05%	-0.25%	-0.01%
Income Tax+	75.81M	12.14M	-47.25M	50K	9.94M	-20.1M	1.35M	-17.55M	-3.15M	-30.8M
Effective Tax Rate %	-17.57%	0.96%	5.7%	0.99%	0.87%	0.59%	1.14%	0.47%	0.98%	8.33%
Net Income+	-69.48M	62.61M	116.58M	9.89M	64.85M	-28.87M	-11.29M	-14.26M	-164.17M	-59.5M
Net Margin %	-0.12%	0.09%	0.18%	0.01%	0.07%	-0.06%	-0.02%	-0.02%	-0.25%	-0.1%
Net Income Growth %	-5.89%	1.9%	0.86%	-0.92%	5.56%	-1.45%	0.61%	-0.26%	-10.52%	0.64%
Net Income (Continuing)	-71.86M	10.69M	67.72M	-61.13M	-26.36M	-28.87M	-11.29M	-12.88M	-164.17M	23.66M
Discontinued Operations	0	51.92M	48.75M	0	91.22M	139.62M	0	0	0	-83.16M
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-1.01	0.89	1.64	0.14	0.88	-0.39	-0.15	-0.22	-3.09	-1.30
EPS Growth %	-5.81%	1.88%	0.84%	-0.91%	5.29%	-1.44%	0.62%	-0.47%	-13.05%	0.58%
EPS (Basic)	-1.02	0.90	1.65	0.14	0.88	-0.39	-0.15	-0.22	-3.09	-1.30
Diluted Shares Outstanding	68.51M	70.48M	70.94M	72.39M	73.85M	74.45M	74.9M	66.25M	53.17M	45.9M
Basic Shares Outstanding	68.37M	69.58M	70.49M	71.99M	73.56M	74.23M	74.9M	66.25M	53.17M	45.74M
Dividend Payout Ratio	-	0.45%	0.24%	2.92%	0.46%	-	-	-	-	-

Balance Sheet

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Current Assets+	299.33M	352.01M	564.81M	648.2M	649.45M	777.37M	2.46B	1.42B	832.81M	708.34M
Cash & Short-Term Investments	85.13M	101.65M	243.99M	335.77M	295.72M	227.51M	1.57B	1.02B	462.09M	340.92M
Cash Only	85.09M	101.62M	197.71M	301.64M	295.65M	227.43M	658.27M	678.91M	310.93M	279.78M
Short-Term Investments	39K	28K	46.28M	34.12M	67K	81K	911.76M	338.87M	151.16M	61.14M
Accounts Receivable	106.37M	93.47M	125.19M	165.6M	94.79M	119.88M	163.76M	156.53M	172.71M	142.18M
Days Sales Outstanding	69.29	49.24	72.35	77.31	38.56	85.18	107.6	85.91	96.05	87.39
Inventory	92.57M	106.39M	96.99M	99.44M	114.83M	60.4M	85.54M	128.2M	115.26M	74.96M
Days Inventory Outstanding	93.28	91.27	91.83	78.04	81.03	81.68	104.11	116.42	107.06	84.56
Other Current Assets	15.27M	60.67M	97.89M	0	222.86M	318.53M	507.38M	116.44M	82.75M	150.28M
Total Non-Current Assets+	386.57M	414.62M	531.2M	868.86M	909.67M	1.04B	1.26B	1.47B	1.27B	1.35B
Property, Plant & Equipment	54.88M	58.46M	59.99M	100.67M	117.67M	130.72M	154.47M	205.74M	266.65M	208M
Fixed Asset Turnover	10.21x	11.85x	10.53x	7.77x	7.63x	3.93x	3.60x	3.23x	2.46x	2.85x
Goodwill	202.14M	233.64M	255.88M	488.6M	501.54M	469.36M	513.62M	784.34M	691.41M	702.39M
Intangible Assets	81.84M	83.52M	99.96M	251.17M	218.32M	186.53M	178.4M	294.3M	248.03M	101.81M
Long-Term Investments	33.37M	31.23M	7.24M	2.85M	3.1M	3.6M	352.02M	111.34M	49.45M	247.19M
Other Non-Current Assets	12.35M	6.07M	64.35M	20.51M	64.07M	241.9M	57.09M	70.47M	10.86M	91.12M
Total Assets+	685.9M	766.63M	1.1B	1.52B	1.56B	1.82B	3.72B	2.89B	2.1B	2.06B
Asset Turnover	0.82x	0.90x	0.58x	0.52x	0.58x	0.28x	0.15x	0.23x	0.31x	0.29x
Asset Growth %	-0.1%	0.12%	0.43%	0.38%	0.03%	0.17%	1.04%	-0.22%	-0.27%	-0.02%
Total Current Liabilities+	119.79M	146.78M	165.37M	272.99M	211.12M	345.09M	230.55M	210.93M	204.84M	237.67M
Accounts Payable	41.13M	49.1M	44.72M	58.92M	25.69M	42.36M	38.65M	35.8M	44.43M	37.72M
Days Payables Outstanding	41.44	42.12	42.35	46.24	18.13	57.29	47.04	32.51	41.27	42.56
Short-Term Debt	0	0	2M	829K	827K	0	0	0	0	0
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	34.89M	39.82M	44.79M	52.45M	111.5M	162.12M	81.83M	99.23M	104.5M	122.17M
Current Ratio	2.50x	2.40x	3.42x	2.37x	3.08x	2.25x	10.67x	6.73x	4.07x	2.98x
Quick Ratio	1.73x	1.67x	2.83x	2.01x	2.53x	2.08x	10.30x	6.12x	3.50x	2.66x
Cash Conversion Cycle	121.13	98.39	121.84	109.11	101.47	109.57	164.67	169.82	161.83	129.4
Total Non-Current Liabilities+	12.42M	12.21M	212.81M	104.77M	134.39M	149.09M	122.19M	140.29M	126.23M	94.92M
Long-Term Debt	0	0	194.07M	50.31M	49.59M	49.68M	0	0	0	51.24M
Capital Lease Obligations	0	0	0	0	18.91M	45.09M	49.23M	60.44M	60.13M	51.24M
Deferred Tax Liabilities	5.59M	5.43M	8.24M	38.91M	36.97M	15M	66.24M	0	54.18M	18.25M
Other Non-Current Liabilities	9.51M	8.46M	11.6M	33.82M	48.24M	41.3M	72.96M	79.86M	11.93M	23.35M
Total Liabilities	132.22M	158.98M	378.18M	377.76M	345.51M	494.18M	352.74M	351.22M	331.07M	332.6M
Total Debt+	0	0	196.07M	51.14M	82.27M	94.77M	49.23M	60.44M	70.68M	51.24M
Net Debt	-85.09M	-101.62M	-1.64M	-250.5M	-213.38M	-132.66M	-609.05M	-618.47M	-240.25M	-228.54M
Debt / Equity	-	-	0.27x	0.04x	0.07x	0.07x	0.01x	0.02x	0.04x	0.03x
Debt / EBITDA	-	-	2.88x	0.51x	0.57x	9.18x	0.99x	4.85x	-	0.63x
Net Debt / EBITDA	-2.64x	-1.11x	-0.02x	-2.48x	-1.48x	-12.85x	-12.25x	-49.64x	-	-2.82x
Interest Coverage	26.99x	157.14x	3.30x	2.09x	26.65x	-22.85x	-0.87x	-	-	-
Total Equity+	553.69M	607.64M	717.83M	1.14B	1.21B	1.33B	3.36B	2.53B	1.77B	1.73B
Equity Growth %	-0.12%	0.1%	0.18%	0.59%	0.07%	0.09%	1.54%	-0.25%	-0.3%	-0.02%
Book Value per Share	8.08	8.62	10.12	15.74	16.43	17.80	44.91	38.25	33.27	37.63
Total Shareholders' Equity	553.69M	607.64M	717.83M	1.14B	1.21B	1.33B	3.36B	2.53B	1.77B	1.73B
Common Stock	821K	833K	841K	857K	873K	878K	885K	713K	590K	594K
Retained Earnings	-1.12B	-1.08B	-994.07M	-586.08M	-551.07M	-470.05M	1.66B	1.64B	1.48B	1.42B
Treasury Stock	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M	-200.96M
Accumulated OCI	15.17M	15.21M	13.59M	3.51M	21.92M	19.35M	-83.92M	-62.43M	-13.46M	-22.21M
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Cash from Operations+	39.55M	96.22M	73.96M	90.9M	37.87M	149.86M	-466.05M	17.49M	50.29M	72.18M
Operating CF Margin %	0.07%	0.14%	0.12%	0.12%	0.04%	0.29%	-0.84%	0.03%	0.08%	0.12%
Operating CF Growth %	-0.1%	1.43%	-0.23%	0.23%	-0.58%	2.96%	-4.11%	1.04%	1.88%	0.44%
Net Income	-69.48M	62.61M	116.46M	437.75M	64.85M	110.75M	2.13B	-14.26M	-164.17M	-59.5M
Depreciation & Amortization	28.05M	28.15M	37.43M	54.45M	65.5M	65.33M	53.7M	85.58M	90.74M	61.21M
Stock-Based Compensation	11.74M	17.28M	19.82M	13.05M	10.65M	34.86M	10.67M	9.38M	14.47M	20.88M
Deferred Taxes	70.27M	517K	-45.22M	-15.16M	-5.41M	-17.27M	24.47M	-28.65M	-16.07M	-27.15M
Other Non-Cash Items	-1.27M	-11.64M	-7.94M	-411.12M	-90.72M	14.8M	-2.62B	-16.71M	122.28M	99.75M
Working Capital Changes	242K	-691K	-46.59M	4.86M	-12.67M	-51.21M	-72.13M	-17.85M	3.04M	-23M
Change in Receivables	-1.8M	-11.18M	-29.21M	-12.5M	-18.75M	-69.64M	-31.4M	33.99M	-11.59M	-24.56M
Change in Inventory	8.56M	-12.79M	-24.36M	-2.93M	-13.14M	-50.44M	-66.63M	8.25M	3.29M	-3.97M
Change in Payables	-5.14M	7.85M	5.46M	5.21M	792K	30.97M	-3.93M	-14.71M	9.2M	1.04M
Cash from Investing+	-10.87M	-54.19M	-148.47M	211.31M	-22.74M	-146.35M	1.47B	431.38M	224.74M	-90.46M
Capital Expenditures	-12.85M	-12.92M	-12.79M	-23.86M	-39.92M	-52.8M	-77.44M	-39.44M	-37.39M	-33.86M
CapEx % of Revenue	0.02%	0.02%	0.02%	0.03%	0.04%	0.1%	0.14%	0.06%	0.06%	0.06%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	985K	100K	200K	677.88M	-1M	2M	1.66B	29.31M	1.48M	5.35M
Cash from Financing+	-25.96M	-25.92M	170.28M	-191.16M	-27.02M	-25.91M	-62.76M	-844.08M	-659.21M	-9.59M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-27.5M	-27.93M	-28.29M	-28.89M	-29.51M	-29.73M	-7.49M	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-708K	-28K	-318K	0	0	0	-10.4M	-4.99M	0	-11.38M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	26.7M	83.31M	61.18M	67.04M	-2.06M	97.05M	-543.48M	-21.95M	12.9M	38.32M
FCF Margin %	0.05%	0.12%	0.1%	0.09%	-0%	0.19%	-0.98%	-0.03%	0.02%	0.06%
FCF Growth %	-0.03%	2.12%	-0.27%	0.1%	-1.03%	48.16%	-6.6%	0.96%	1.59%	1.97%
FCF per Share	0.39	1.18	0.86	0.93	-0.03	1.30	-7.26	-0.33	0.24	0.84
FCF Conversion (FCF/Net Income)	-0.57x	1.54x	0.63x	9.19x	0.58x	-5.19x	41.29x	-1.23x	-0.31x	-1.21x
Interest Paid	114K	200K	6.54M	20.8M	2.16M	1.44M	469K	0	0	0
Taxes Paid	4.93M	8.14M	21.05M	16.99M	102.01M	38.02M	452.46M	43.07M	2.7M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	-11.72%	10.78%	17.59%	1.07%	5.51%	-2.27%	-0.48%	-0.48%	-7.63%	-3.4%
Return on Invested Capital (ROIC)	0.62%	9.87%	3.85%	4.35%	6.23%	-3.18%	-0.15%	-2.35%	-8.74%	1.21%
Gross Margin	35.35%	38.59%	38.96%	40.51%	42.35%	47.46%	46.01%	39.57%	40.13%	45.52%
Net Margin	-12.4%	9.04%	18.46%	1.26%	7.23%	-5.62%	-2.03%	-2.14%	-25.01%	-10.02%
Debt / Equity	-	-	0.27x	0.04x	0.07x	0.07x	0.01x	0.02x	0.04x	0.03x
Interest Coverage	26.99x	157.14x	3.30x	2.09x	26.65x	-22.85x	-0.87x	-	-	-
FCF Conversion	-0.57x	1.54x	0.63x	9.19x	0.58x	-5.19x	41.29x	-1.23x	-0.31x	-1.21x
Revenue Growth	1.38%	23.66%	-8.85%	23.8%	14.76%	-42.75%	8.14%	19.73%	-1.32%	-9.52%

Revenue by Segment

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Service	-	-	45.73M	276.82M	323.4M	-	374.55M	387.88M	412.92M	420.63M
Service Growth	-	-	-	505.32%	16.83%	-	-	3.56%	6.45%	1.87%
Product	-	-	150.37M	504.03M	573.88M	-	180.95M	277.19M	243.41M	173.19M
Product Growth	-	-	-	235.20%	13.86%	-	-	53.19%	-12.19%	-28.85%
Services	-	-	-	-	-	332.67M	-	-	-	-
Services Growth	-	-	-	-	-	-	-	-	-	-
Products	-	-	-	-	-	181.04M	-	-	-	-
Products Growth	-	-	-	-	-	-	-	-	-	-
Brooks Life Science Systems	61.57M	81.96M	-	-	-	-	-	-	-	-
Brooks Life Science Systems Growth	-	33.12%	-	-	-	-	-	-	-	-
Brooks Semiconductor Solutions Group	76.97M	77.31M	-	-	-	-	-	-	-	-
Brooks Semiconductor Solutions Group Growth	-	0.43%	-	-	-	-	-	-	-	-
Operatings	138.54M	-	-	-	-	-	-	-	-	-
Operatings Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Europe	-	-	-	-	139.77M	108.81M	104.82M	109.86M	102.77M	107.37M
Europe Growth	-	-	-	-	-	-22.15%	-3.66%	4.80%	-6.45%	4.47%
CHINA	-	-	-	-	-	-	48.09M	51.79M	58.26M	58.35M
CHINA Growth	-	-	-	-	-	-	-	7.68%	12.50%	0.15%
UNITED KINGDOM	-	-	-	-	-	-	-	26.76M	27.45M	35.39M
UNITED KINGDOM Growth	-	-	-	-	-	-	-	-	2.57%	28.91%
Asia Pacific	247.24M	327.86M	262.71M	-	-	-	-	-	39.67M	23.28M
Asia Pacific Growth	-	32.61%	-19.87%	-	-	-	-	-	-	-41.32%
North America	209.73M	242.33M	233.24M	327.25M	340.4M	323.98M	373.61M	359.42M	366.21M	-
North America Growth	-	15.55%	-3.75%	40.30%	4.02%	-4.82%	15.32%	-3.80%	1.89%	-
Africa	-	-	-	-	-	-	-	65.09M	61.96M	-
Africa Growth	-	-	-	-	-	-	-	-	-4.81%	-
Asia Pacific, Other than China	-	-	-	-	417.1M	80.92M	28.97M	52.16M	-	-
Asia Pacific, Other than China Growth	-	-	-	-	-	-80.60%	-64.20%	80.04%	-	-
U	-	240.6M	232.7M	325.3M	-	-	-	-	-	-
U Growth	-	-	-3.28%	39.79%	-	-	-	-	-	-
Asia Pacific And Other	-	-	-	312.24M	-	-	-	-	-	-
Asia Pacific And Other Growth	-	-	-	-	-	-	-	-	-	-
Europe Excluding United Kingdom	-	80.55M	83.92M	92.6M	-	-	-	-	-	-
Europe Excluding United Kingdom Growth	-	-	4.18%	10.34%	-	-	-	-	-	-
G	-	42.14M	51.69M	48.76M	-	-	-	-	-	-
G Growth	-	-	22.67%	-5.66%	-	-	-	-	-	-
Europe, Excluding United Kingdom	66.74M	-	-	-	-	-	-	-	-	-
Europe, Excluding United Kingdom Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Azenta, Inc. (AZTA) reported $594.1M in revenue for fiscal year 2025. This represents a 14% increase from $519.5M in 2012.

Azenta, Inc. (AZTA) saw revenue decline by 9.5% over the past year.

Azenta, Inc. (AZTA) reported a net loss of $59.5M for fiscal year 2025.

Dividend & Returns

Azenta, Inc. (AZTA) has a return on equity (ROE) of -3.4%. Negative ROE indicates the company is unprofitable.

Azenta, Inc. (AZTA) generated $38.3M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.